BREAKING: Futures Jump On Megacap Tech Earnings Alexion Pharmaceuticals (ALXN), featured in today's IBD 50 Stocks To Watch, has a late-stage Covid-19 study underway in the heated race for a coronavirus drug."We view this settlement as a deck-clearing event that could also make the Alexion story cleaner for an acquirer," Piper Sandler, which has a buy rating on the stock, said in a note to clients.